Despite and perhaps because of the advances in biomedicine over the past few decades, chronic diseases, like heart disease, stroke, and diabetes are now rising in many places of the world and more worryingly they impose their heaviest burden on the poor and disadvantaged populations.
In 2002, 3.5 million people died of cancer in Asia. This is expected to increase to 8.1 million by 2020. As the death rate and prevalence of cancer hits hard in Asia, specific concerns have been raised about the economic toll of the disease on patients and their families. Ongoing treatments are expensive and can impose a considerable financial burden.
One quarter of the world’s adult population suffers from hypertension, and although it has no obvious symptoms, it can lead to heart attacks, stroke, kidney failure and blindness. Despite this, there has been great uncertainty as to how intensively blood pressure should be lowered to obtain maximal benefit and minimize risks.
Una O’Brien CB, Permanent Secretary at the Department of Health, and staff from the British Embassy in Beijing visited The George Institute for Global Health, China’s offices in Beijing to discuss the health issues affecting people in not only China and the UK, but people all around the world.
Professor Chris Maher, Director of the Musculoskeletal Division at The George Institute for Global Health, said that the new back pain tool — Back Pain Choices — synthesises recommendations from evidence-based practice guidelines in Australia, the UK and USA into a unified set of recommendations.